TP53 and head and neck squamous cell carcinoma: LRPS has a potential to be a promising indicator of overall survival, prognosis, TP53 status, and immune characteristics in HNSCC, and perhaps could monitor and guide the treatment efficacy and prognosis of HNSCC in the future.